Clinical predictors of response to atezolizumab/bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.

Odent AV, Campani C, Bouattour M, Touchefeu Y, Delhoume V, Rosmorduc O, Pascale A, An J, Lee HC, Regnault H, Thabut D, Amaddeo G, Ningararhi M, Olivier-Hourmand I, Metivier C, Ronot M, Ntandja-Wandji L, Ozenne V, Sidali S, Marra F, Hollande C, Ganne-Carrié N, Nahon P, Peron JM, Lequoy M, Sharma R, Paris Liver Cancer Group, Trepo E, Mouri S, Allaire M, Shim JH, Nault JC

Open source

DOI: 10.1016/j.jhepr.2026.101915
Published: 2026 Sep
Container: JHEP reports : innovation in hepatology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jhepr.2026.101915,
  title = {Clinical predictors of response to atezolizumab/bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.},
  author = {Odent AV and Campani C and Bouattour M and Touchefeu Y and Delhoume V and Rosmorduc O and Pascale A and An J and Lee HC and Regnault H and Thabut D and Amaddeo G and Ningararhi M and Olivier-Hourmand I and Metivier C and Ronot M and Ntandja-Wandji L and Ozenne V and Sidali S and Marra F and Hollande C and Ganne-Carrié N and Nahon P and Peron JM and Lequoy M and Sharma R and Paris Liver Cancer Group and Trepo E and Mouri S and Allaire M and Shim JH and Nault JC},
  year = {2026},
  journal = {JHEP reports : innovation in hepatology},
  doi = {10.1016/j.jhepr.2026.101915},
  url = {https://doi.org/10.1016/j.jhepr.2026.101915}
}

RIS

TY  - JOUR
TI  - Clinical predictors of response to atezolizumab/bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.
AU  - Odent AV
AU  - Campani C
AU  - Bouattour M
AU  - Touchefeu Y
AU  - Delhoume V
AU  - Rosmorduc O
AU  - Pascale A
AU  - An J
AU  - Lee HC
AU  - Regnault H
AU  - Thabut D
AU  - Amaddeo G
AU  - Ningararhi M
AU  - Olivier-Hourmand I
AU  - Metivier C
AU  - Ronot M
AU  - Ntandja-Wandji L
AU  - Ozenne V
AU  - Sidali S
AU  - Marra F
AU  - Hollande C
AU  - Ganne-Carrié N
AU  - Nahon P
AU  - Peron JM
AU  - Lequoy M
AU  - Sharma R
AU  - Paris Liver Cancer Group
AU  - Trepo E
AU  - Mouri S
AU  - Allaire M
AU  - Shim JH
AU  - Nault JC
PY  - 2026
JO  - JHEP reports : innovation in hepatology
DO  - 10.1016/j.jhepr.2026.101915
UR  - https://doi.org/10.1016/j.jhepr.2026.101915
ER  -

APA

AV, O., C, C., M, B., Y, T., V, D., O, R., A, P., J, A., HC, L., H, R., D, T., G, A., M, N., I, O., C, M., M, R., L, N., V, O., S, S., F, M., C, H., N, G., P, N., JM, P., M, L., R, S., Group, P. L. C., E, T., S, M., M, A., JH, S., & JC, N. (2026). Clinical predictors of response to atezolizumab/bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.. JHEP reports : innovation in hepatology. https://doi.org/10.1016/j.jhepr.2026.101915

Source records

pubmed · retrieved 2026-09-27T14:34:44.852Z